当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析 - 现金流量表

赛升药业

(300485)

  

流通市值:26.42亿  总市值:46.48亿
流通股本:2.74亿   总股本:4.82亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金110,983,425.49476,536,386.56350,257,520.72228,375,313.04
  收到的税费返还-2,345,343.292,346,593.292,346,593.29
  收到其他与经营活动有关的现金904,322.387,884,244.371,417,318.07288,639.15
  经营活动现金流入小计111,887,747.87486,765,974.22354,021,432.08231,010,545.48
  购买商品、接受劳务支付的现金35,237,595.21108,427,218.7875,504,042.8449,541,537.88
  支付给职工以及为职工支付的现金17,934,416.1576,682,799.7857,841,323.9338,750,125.46
  支付的各项税费7,250,087.3960,597,665.8644,020,780.2630,589,303.66
  支付其他与经营活动有关的现金40,513,938.27213,979,553.98146,213,331.0982,787,678.46
  经营活动现金流出小计100,936,037.02459,687,238.4323,579,478.12201,668,645.46
  经营活动产生的现金流量净额10,951,710.8527,078,735.8230,441,953.9629,341,900.02
二、投资活动产生的现金流量:
  收回投资收到的现金60,627,658.1149,151,187.241,364,233.9330,762,094.12
  取得投资收益收到的现金485,589.5342,294,822.7432,728,369.475,146,725.99
  处置固定资产、无形资产和其他长期资产收回的现金净额-180,000180,000180,000
  收到的其他与投资活动有关的现金344,804,0001,048,683,582.031,879,895,582.03490,379,143.52
  投资活动现金流入小计405,917,247.641,140,309,591.971,954,168,185.43526,467,963.63
  购建固定资产、无形资产和其他长期资产支付的现金3,714,866.06100,281,404.5345,066,852.5529,547,965.45
  支付其他与投资活动有关的现金366,184,0001,085,753,698.631,945,170,852.8524,809,000
  投资活动现金流出小计369,898,866.061,186,035,103.161,990,237,705.35554,356,965.45
  投资活动产生的现金流量净额36,018,381.58-45,725,511.19-36,069,519.92-27,889,001.82
三、筹资活动产生的现金流量:
  取得借款收到的现金-19,987,80019,987,800-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-19,987,80019,987,800-
  分配股利、利润或偿付利息支付的现金245,443.17250,888.94--
  筹资活动现金流出平衡项目00--
  筹资活动现金流出小计245,443.17250,888.94--
  筹资活动产生的现金流量净额平衡项目000-
  筹资活动产生的现金流量净额-245,443.1719,736,911.0619,987,800-
四、汇率变动对现金及现金等价物的影响-400,326.58-528,891.61-298,613.9-105,771.77
五、现金及现金等价物净增加额46,324,322.68561,244.0814,061,620.141,347,126.43
  加:期初现金及现金等价物余额75,823,934.3975,262,690.3175,262,690.3175,262,690.31
  期末现金及现金等价物余额122,148,257.0775,823,934.3989,324,310.4576,609,816.74
补充资料:
  净利润-7,789,641.78-45,755,010.5
  资产减值准备-16,823,474.14-1,143,047.16
  固定资产和投资性房地产折旧-44,541,995.11-22,807,516.02
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-44,541,995.11-22,807,516.02
  无形资产摊销-2,439,162.84-1,891,989.81
  处置固定资产、无形资产和其他长期资产的损失--111,881.57--111,881.57
  固定资产报废损失-119,043.88--
  公允价值变动损失--8,607,096.73--38,542,068.26
  财务费用-100,922.43--
  投资损失--28,538,742.24--7,452,845.57
  递延所得税--443,355.76-5,902,576.36
  其中:递延所得税资产减少--495,001.96--170,974.58
    递延所得税负债增加-51,646.2-6,073,550.94
  存货的减少-8,403,496.72--1,524,844.08
  经营性应收项目的减少--12,404,461.25-3,609,797.82
  经营性应付项目的增加--5,488,216.07--4,311,804.24
  其他-2,103,940.43--
  现金的期末余额-50,754,290.93-76,609,816.74
  减:现金的期初余额-75,262,690.31-75,262,690.31
  加:现金等价物的期末余额-25,069,643.46--
  现金及现金等价物的净增加额-561,244.08-1,347,126.43
公告日期2026-04-292026-03-312025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑